Clin2
NCT07358520Possibly a fitNot yet recruiting

Huaier granules for proteinuria from lung cancer drug treatment

Proteinuria

Treatments studied

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial tests if Huaier Granules, a traditional Chinese medicine, can reduce protein in the urine caused by the cancer drugs Bevacizumab or Anlotinib in lung cancer patients. It may help manage a side effect that affects kidney health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with lung cancer (confirmed by a biopsy).
  • You are currently being treated with the drugs Bevacizumab or Anlotinib.
  • You have protein in your urine, with levels between 0.15 grams and 3.5 grams per 24 hours.
  • You have not taken Huaier Granules in the last month.
  • Your doctor expects you to live at least 6 months or more.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07355361Not yet recruiting· Phase 2
Huaier Granule for proteinuria in breast cancer patients

This trial tests if Huaier Granule, a traditional Chinese medicine, can reduce protein in the urine of breast cancer patients. It is for women who have proteinuria after immunotherapy or anti-angiogenic therapy.

Shanghai, Shanghai Municipality
NCT05860907Not yet recruiting· Phase 4
Huaier granules for advanced breast cancer without spread to organs

This trial studies whether Huaier granules can slow or control advanced breast cancer that has not spread to internal organs (like the liver or lungs). It may help people who have limited treatment options, especially when standard stronger local treatments (surgery or radiation) aren’t being used.

Shijiazhuang, Hebei
NCT05839314Recruiting· Phase 4
Huaier granules for idiopathic membranous nephropathy with PLA2R

This trial studies whether Huaier granules can improve kidney disease activity in people with “idiopathic membranous nephropathy” who test positive for PLA2R antibodies and are still not in remission. Participants will also have been on standard blood-pressure/kidney-protecting treatment (called RASI) for at least 4 weeks.

Beijing, Beijing Municipality
NCT05871437Not yet recruiting· Phase 4
Huaier granules to lower breast cancer tumor markers after surgery

This trial tests whether Huaier granules can reduce blood “tumor marker” levels in people with breast cancer after surgery. If your marker levels are high but scans show no spread, the study may help see if the granules can keep markers from staying elevated.

Shanghai, Shanghai Municipality
NCT06109454Recruiting
Huaier granules after lung cancer surgery

This study tests whether Huaier granules can help prevent lung cancer from coming back after surgery. It is for people with stage II–IIIA non-small cell lung cancer who have recently had their tumor completely removed and have not had other treatments like chemotherapy or radiation.

Shenyang, Liaoning
NCT06368063Recruiting· Phase 4
Huaier granules after pancreatic cancer surgery

This trial tests whether a Chinese herbal medicine called Huaier granules works better than standard chemotherapy for people with pancreatic cancer that was removed by surgery. Participants can choose to take Huaier granules or standard chemotherapy, and researchers will compare outcomes.

Xi'an, Shannxi

Hear when a new Proteinuria trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.